Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06225219 · ClinicalTrials.gov registry record

Establishing the Chaplain Role in a Primary Care Clinic Setting

A clinical trial, sponsored by Methodist Health System.

Completed
Registry status
312
Enrollment target

NCT06225219: Completed study, sponsored by Methodist Health System.

NCT06225219 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 312 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06225219 has completed, sponsored by Methodist Health System.

COMPLETED
Registry status
312 participants
Enrollment target

Study Summary

In 2019, a full-time chaplain was placed in the Golden Cross Academic Clinic (GCAC), with the chaplain's focus being in the primary care internal medicine department. While research exists regarding chaplains in the inpatient setting, research regarding the presence of a full-time chaplain in a primary care setting as well as the topics patients discuss with that chaplain are limited.

Primary Outcome

Number of request from the patients or provider for chaplain

Interventions

  • BEHAVIORAL Counseling

Trial Details

FieldValue
Enrollment Target 312 participants
Start Date 2023-06-20
Est. Completion 2025-06-18
Methodist Health System

125 total trials

What the finished NCT06225219 record still lists

NCT06225219 is an observational study that tracks outcomes without assigning an intervention. The registered 312 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Counseling is the first listed.

NCT06225219 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06225219 about?

NCT06225219 is a clinical study titled "Establishing the Chaplain Role in a Primary Care Clinic Setting". In 2019, a full-time chaplain was placed in the Golden Cross Academic Clinic (GCAC), with the chaplain's focus being in the primary care internal medicine department. While research exists regarding chaplains in the inpatient setting, research regarding the presence of a full-time chaplain in a prim...

What is the current status of trial NCT06225219?

This trial is currently completed. The enrollment target is 312 participants. The study started on 2023-06-20. Estimated completion is 2025-06-18.

What interventions are being tested in trial NCT06225219?

The interventions under investigation include: Counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT06225219?

This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04984551 · 312 participants · Phase 2

    Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

  • NCT04999904 · 312 participants · NA

    A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability

  • NCT05220332 · 312 participants · NA

    Church-based Intervention to Improve Blood Pressure in African Americans

  • NCT05434234 · 312 participants · Phase 1

    A Study of YL201 in Patients With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06225219, the US trial registry maintained by the National Library of Medicine. NCT06225219 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.